History and ongoing work of AORTIC
History and ongoing work of AORTIC
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya
Subset of breast cancer patients found to benefit from neratinib in latest trial
Role of AORTIC in dealing with rising cancer rates in Africa
New drug demonstrates early promise in metastatic breast cancer
New tools can help tackle flawed decision-making process for HER2- patients
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy
EBCC 2014 key messages to doctors
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
The future of mCRPC treatment - expert discussion
mCRPC management in Taiwan - expert interview
PSA as a marker of disease in patients with prostate cancer and bone metastases